Polymorphonuclear neutrophil (PMN) phagocytic function has been shown to be impaired in some patients with periodontitis. PMN constitutively express members of two immunoglobulin G receptor (Fc␥R) classes: Fc␥RIIa (CD32) and Fc␥RIIIb (CD16). Both receptors exhibit genetically determined structural and functional biallelic polymorphisms, which have been shown to influence PMN phagocytic function. In this study, we assessed the relevance of these Fc␥R polymorphisms to susceptibility to adult periodontitis and recurrence rate. The distribution of Fc␥RIIa and Fc␥RIIIb genotypes of 100 Japanese patients with adult periodontitis during follow-up was compared to the distribution of genotypes in 105 race-matched healthy controls. No significant skewing of distributions of Fc␥RIIa and Fc␥RIIIb genotypes was observed between patients and controls. Notably, however, a significant overrepresentation of the Fc␥RIIIb-NA2 allotype was found in patients with disease recurrence (P < 0.05; odds ratio, 4.29; 95% confidence interval, 1.19 to 16.24). Moreover, the annual rate of recurrence was significantly higher in patients with the Fc␥RIIIb-NA2/NA2 and Fc␥RIIIb-NA1/NA2 genotypes than in Fc␥RIIIb-NA1/NA1 individuals (P < 0.05). Fc␥RIIa-R/R131 individuals also exhibited higher recurrence rates, though the difference was not statistically significant (P ‫؍‬ 0.06). These results suggest that the Fc␥RIIIb-NA2 allotype represents a risk factor for recurrence of adult periodontitis.
Adult periodontitis, which is a major cause of tooth loss, is characterized by destruction of periodontal tissues. Some patients respond poorly to conventional treatment and suffer from recurrence, which results in progressive attachment loss (8, 16) . This recurrence might be associated with compromised function of polymorphonuclear neutrophils (PMN) (15, 20) .
Polymorphisms of the receptors for the constant part of immunoglobulin G (IgG) (Fc␥R) have been shown to influence PMN phagocytic function (2, 22, 24, 25) . Human PMN constitutively express members of two Fc␥R classes, Fc␥RIIa (CD32) and Fc␥RIIIb (CD16), both of which exhibit genetically determined structural and functional biallelic polymorphisms (4, 17, 18, 30) .
Fc␥RIIa exhibits either an arginine (Fc␥RIIa-R131) or a histidine (Fc␥RIIa-H131) at amino acid position 131 in the ligand binding site. This difference was found to be critical for the binding of human IgG2 complexes (22, 31) . In vitro studies showed that PMN obtained from Fc␥RIIa-H/H131 individuals internalize human IgG2-opsonized particles more efficiently than those from Fc␥RIIa-R/R131 individuals (1, 2, 26, 27) . Since IgG2 is considered an important subclass in the defense against encapsulated bacteria (11) , the hypothesis that the Fc␥RIIa-R/R131 genotype constitutes a risk factor for such infections was put forward (1, 27) . Furthermore, a role for this Fc␥RIIa polymorphism in the pathogenesis of localized juvenile periodontitis has been proposed (33) .
The two allelic forms (allotypes) of the PMN-specific Fc␥RIIIb differ by four amino acids and two potential glycosylation sites (10, 17, 18, 29) . PMN from Fc␥RIIIb-NA2/NA2 individuals were shown to exhibit lower phagocytic capacities of human IgG1 and IgG3 complexes than those of Fc␥RIIIb-NA1/NA1 individuals (3, (23) (24) (25) 29) . To determine whether Fc␥R allotypes influence incidence of adult periodontitis or clinical outcome, we compared the distributions of Fc␥RIIa and Fc␥RIIIb genotypes between Japanese patients and racematched healthy controls, as well as between patients with and without recurrence of disease.
MATERIALS AND METHODS
Study subjects. One hundred Japanese patients with adult periodontitis (21) (48 male and 52 female; age range, 34 to 67 years; mean age, 47.8 years) referred to the Periodontal Clinic of the Niigata University Dental Hospital and 105 Japanese healthy volunteers (73 male and 32 female; age range, 23 to 63 years; mean age, 27.0 years) were included in the study. Informed consent was obtained from all participants. None of the participants had a history or current signs of systemic disease, nor had they used any medication 3 months prior to the study; none had been fitted with removable prosthodontic appliances.
Clinical assessments. Clinical assessment of the patients was performed by the same periodontist at the first visit (baseline), the completion of treatment (follow-up start), and the latest recall appointment. Probing depth (from free gingival margin to bottom of pocket) and attachment level (from cement-enamel junction to bottom of pocket) of all teeth were assessed by using a Williams probe at six sites: mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual. Measurements were recorded to the nearest millimeter, and every observation close to 0.5 mm was rounded to the lower whole number. All Japanese patients with adult periodontitis were treated by conventional periodontal therapy consisting of oral hygiene instruction, scaling, root planing, and periodontal surgery. When the patients were considered free from all periodontal lesions, they were monitored clinically at 3-month intervals for more than 1 year (mean, 38.9 months) posttherapy. The mean number of teeth in the patients was 25.7 (standard deviation ϭ 3.4) at the follow-up start. Recurrence of periodontitis was defined as having more than one diseased site with a loss of Ն2 mm in attachment level in the entire dentition during follow-up. Annual rate of disease recurrence of individual patients was also expressed as the percentage of diseased sites with a loss of Ն2 mm in attachment level in the entire dentition per year (7, 12, 35) . Preparation of cells and sera. PMN were isolated from peripheral blood by sedimentation with 5% dextran (Nacalai Tesque Inc., Kyoto, Japan) solution (4 volumes of blood, 1 volume of dextran) for 20 min at 37°C. After removal of erythrocytes by isotonic cell lysis (with NH 4 Cl for 10 min, room temperature), PMN were washed with phosphate-buffered saline, resuspended in phosphatebuffered saline at 10 6 PMN/ml, and used immediately. Serum was removed after centrifugation of the clot, recentrifuged to eliminate residual erythrocytes, and stored at Ϫ70°C until used.
MAbs. Anti-Fc␥RII (CD32) monoclonal antibody (MAb) IV.3 (IgG2b [13] ) was obtained from Medarex (Annandale, N.J.). Anti-Fc␥RII MAb 41H.16 (IgG2a [6] ) was kindly provided by B. M. Longenecker (University of Alberta, Edmonton, Canada). Anti-Fc␥RIII (CD16) MAb MG38 (IgG1 [28] ) was obtained from Nichirei Co. (Tokyo, Japan), and anti-Fc␥RIII MAb GRM1 (IgG2a [10] ) was obtained from Harlan Sera-lab Co. (Sussex, England).
Determination of Fc␥RIIa and Fc␥RIIIb phenotypes and genotypes. Fc␥RIIa allotyping of PMN was performed by flow cytometry as described previously (26) . In short, PMN were incubated with CD32 MAb IV.3, which reacts with both Fc␥RIIa allotypes (13) , and MAb 41H.16, which selectively binds the Fc␥RIIa-R131 allotype (6) . PMN were labeled for single-fluorescence flow cytometry, using phycoerythrin-conjugated F(abЈ) 2 fragments of goat antimouse IgG (Caltag, San Francisco, Calif.) as a fluorescent label. PMN were analyzed with a FACScan flow cytometer and Consort 30 software (Becton Dickinson, San Jose, Calif.). PMN were gated according to their characteristic forward and sideward scatter pattern. Ten thousand cells were counted per sample. The Fc␥RIIIb-NA1 and -NA2 allotypes were determined by using allotype-specific CD16 MAb MG38, which recognizes Fc␥RIIIb-NA1 (28), and GRM1, which recognizes Fc␥RIIIb-NA2 (10). For genotyping, genomic DNA was isolated from peripheral blood (Easy-DNA kit; Invitrogen, San Diego, Calif.), and Fc␥RIIa and Fc␥RIIIb genotypes were determined by PCR as described before (5, 19) . Coincidence rates of the results obtained by the two methods were 91.2% for Fc␥RIIa and 99.0% for Fc␥RIIIb. In the absence of coincidence, PCR results were used.
Determination of serum IgG subclass levels. Serum IgG subclass concentrations were determined by one-step sandwich enzyme-linked immunosorbent assay (human IgG subclass profile kit; Zymed, San Francisco, Calif.). The optical density of each well was read at a 450-nm wavelength with a microplate reader (Multiskan Bichromatic; Labsystems, Helsinki, Finland). Six standard concentrations (1/500, 1/1,000, 1/2,000, 1/4,000, 1/8,000, and 1/16,000) were used in duplicate to construct the standard curve. Standard curves were prepared by graphing optical density value versus log concentration for each IgG subclass. The IgG subclass concentration of each test sample was calculated from the standard curve.
Statistical analysis. The 2 test was used to compare the Fc␥RIIa and Fc␥RIIIb genotype distributions between Japanese patients with adult periodontitis and race-matched healthy controls and between patients with and without recurrence (3 ϫ 2 contingency table). The same test was used to assess the role of the Fc␥RIIa-R131 and Fc␥RIIIb-NA2 allotypes as a risk factor for recurrence (2 ϫ 2 contingency table; patients with versus patients without recurrence, R/R131 and R/H131 versus H/H131, and NA2/NA2 and NA1/NA2 versus NA1/ NA1). Differences in annual rate of recurrence among the Fc␥RIIa or Fc␥IIIb genotypes were assessed by the Kruskal-Wallis test with pairwise comparisons, using Fisher's multiple-comparison procedure with the StatView. The relevance of each Fc␥R genotype to the annual recurrence rate was determined by multifactorial analysis of variance (ANOVA) with the STATA. Serum IgG subclass levels and clinical parameters in Fc␥RIIa and Fc␥RIIIb genotypes were compared with the Kruskal-Wallis test (StatView). All risk rates were considered significant at 5% (P Ͻ 0.05).
FIG. 1.
Relationship between Fc␥R genotypes and annual rate of disease recurrence. The annual rate of recurrence was expressed as the percentage of diseased sites with a loss of Ն2 mm in attachment level in the entire dentition per year. Each circle represents the annual recurrence rate for one subject. The mean and SE are indicated for each Fc␥R genotype (Fc␥RIIa-R/R131, -IIa-R/ H131, and -IIa-H/H131, 7.38% Ϯ 3.53%, 3.95% Ϯ 0.75%, and 2.59% Ϯ 0.40%, respectively; Fc␥RIIIb-NA1/NA1, -IIIb-NA1/NA2, and -IIIb-NA2/NA2, 1.71% Ϯ 0.32%, 4.34% Ϯ 0.82%, and 4.48% Ϯ 0.90%, respectively). ‫,ء‬ significantly different from the annual recurrence rate for individuals with the Fc␥RIIIb-NA1/ NA1 genotype (Kruskal-Wallis test) (P Ͻ 0.05). 
RESULTS

Distribution of Fc␥R genotypes in periodontitis patients
with and without disease recurrence. We next studied whether there was a relationship between Fc␥R genotypes and recurrence of periodontitis. Distributions of Fc␥RIIa and Fc␥RIIIb genotypes were compared between 85 Japanese adult periodontitis patients with and 15 Japanese adult periodontitis patients without disease recurrence. A significant skewing was observed in the distribution of the Fc␥RIIIb genotypes between these subgroups (Table 2) . Likewise, the Fc␥RIIIb allele frequency differed between the two groups ( Table 2 ). In the patients with recurrence, there was a relative overrepresentation of the Fc␥RIIIb-NA2 allele. Homozygosity for the Fc␥RIIIb-NA2 allele was found in 22.3% of the 85 patients with, compared to 6.7% in the 15 patients without, recurrence (Table 2) . No significant skewing was observed in the distribution of the Fc␥RIIa genotypes between the two subgroups ( Table 2) .
Relationship between Fc␥R genotypes and annual rate of disease recurrence. We compared the mean annual rates of disease recurrence among Fc␥RIIa and Fc␥RIIIb genotype groups in 100 Japanese patients with adult periodontitis. As shown in Fig. 1 , the annual rate of recurrence was significantly higher in patients with the Fc␥RIIIb-NA2/NA2 (mean Ϯ standard error [SE], 4.48 Ϯ 0.90%) and Fc␥RIIIb-NA1/NA2 (4.34 Ϯ 0.82%) genotypes than in those with the IIIb-NA1/ NA1 genotype (1.71 Ϯ 0.32%) (P Ͻ 0.05). Fc␥RIIa genotypes were not linked to the annual rate of recurrence (R/R131, 7.38 Ϯ 3.53% [mean Ϯ SE]; R/H131, 3.95 Ϯ 0.75%; H/H131, 2.59 Ϯ 0.40%) (P ϭ 0.06).
We next verified whether Fc␥RIIa and Fc␥RIIIb genotypes represent independent factors associated with the annual rate of recurrence. Multifactorial ANOVA was used to test which Fc␥R genotype was critical for recurrence rate. As shown in Table 3 , the adequacy of our analysis model was statistically confirmed (P ϭ 0.005), supporting the hypothesis that recurrence rate can be predicted by the Fc␥R genotype. This test also confirmed that Fc␥RIIIb was and Fc␥RIIa was not relevant to the recurrence rate (P ϭ 0.004 for Fc␥RIIIb; P ϭ 0.122 for Fc␥RIIa).
Relationship between Fc␥R genotypes and serum IgG subclass levels in periodontitis patients. We then evaluated whether IgG subclass levels vary between blood donors of the different Fc␥R genotypes. Serum levels of IgG subclasses were noted to vary considerably between individuals. We thus also calculated the proportion of each subclass relative to the total IgG content (11) . IgG subclass levels and relative distributions did not differ between Fc␥RIIa and Fc␥RIIIb genotypes (Table 4).
Clinical parameter values in each Fc␥R genotype group in periodontitis patients. We also sought to determine whether other confounding factors, such as differences in probing depth and/or attachment level at the time of initial examination, could account for differences in disease recurrence patterns. As shown in Table 5 , no significant differences were observed in mean values of clinical parameters, including probing depth and attachment level, between Fc␥RIIa or Fc␥RIIIb genotypes. Furthermore, no significant difference in mean patient age or follow-up period was observed.
DISCUSSION
The pathogenesis of adult periodontitis remains poorly understood. The basis for disease recurrence may be associated with both genetic and environmental factors. In this study, we evaluated the role of leukocyte Fc␥R polymorphisms as heritable risk factors for the onset and recurrence of disease.
Fc␥RIIa and Fc␥RIIIb distributions did not differ between Japanese patients and race-matched controls, indicating that Fc␥R genotypes do not, per se, constitute a risk factor for development of adult periodontitis. However, we noted a positive correlation between the Fc␥RIIIb-NA2 allotype and recurrence of adult periodontitis (Tables 1 and 2 ).
The relevance of Fc␥R genotypes to the recurrence rate was evaluated by multifactorial ANOVA. Results showed that the recurrence rate could be predicted by the occurrence of the two Fc␥R genotypes (P ϭ 0.005). Our data showed Fc␥RIIIb-NA2/NA2 or Fc␥RIIIb-NA1/NA2 patients to have a risk for recurrence of disease two times higher than that of Fc␥RIIIb-NA1/NA1 patients (Fig. 1) . To the best of our knowledge, this is the first study in which evidence for a role of the Fc␥RIIIb-NA2 gene as an independent risk factor for disease has been presented. Only six Japanese patients (6.0%) exhibited the Fc␥RIIa-R/ R131 genotype in this study (Table 1 ). This finding is consistent with the results of previous epidemiological studies showing the Fc␥RIIa-H/H131 genotype to predominate in Japan (19, 23) . Although no significant skewing was observed in the distribution of the Fc␥RIIa genotypes between Japanese patients with and without recurrence, it is noteworthy that all Fc␥RIIa-R/R131 patients exhibited recurrence (Table 2) . Moreover, the mean recurrence rate was approximately three times higher in the Fc␥RIIa-R/R131 individuals than in the Fc␥RIIa-H/H131 individuals, although this difference was not statistically significant (Fig. 1) , likely due to the very small number of Fc␥RIIa-R/R131 individuals in Japan. The hypothesis that Fc␥RIIa polymorphism is important for disease recurrence warrants testing in cohorts consisting of other ethnic populations.
We also investigated whether confounding factors were responsible for the observed correlation. Serum IgG subclass levels were comparable between Fc␥R genotypes (14, 32, 34) (Table 4) . Clinical parameters at baseline and at follow-up start that may influence progression of adult periodontitis were similar for all Fc␥R genotypes (Table 5) . We also did not find differences in the distribution of disease recurrence between Japanese subjects with mild and those with severe adult periodontitis at baseline (data not shown). Smoking has also been proposed to constitute a risk factor for progression of periodontal disease (9, 15) . A retrospective examination showed that the percentages of patients who were reported to be cigarette smokers did not differ significantly among the Fc␥RIIa and Fc␥RIIIb genotypes (data not shown).
In conclusion, the NA1/NA2 polymorphism of Fc␥RIIIb was observed to be closely related to the recurrence of adult periodontitis. To our knowledge, this represents the first study documenting evidence for a role of the Fc␥RIIIb-NA2 allotype as a risk factor in human disease. More extensive studies in larger groups of patients, and also in other ethnic populations, should be undertaken to better assess the putative relevance of the Fc␥RIIa polymorphism to the pathophysiology of adult periodontitis. 
